DE69614407D1 - Pharmazeutische zusammensetzungen - Google Patents

Pharmazeutische zusammensetzungen

Info

Publication number
DE69614407D1
DE69614407D1 DE69614407T DE69614407T DE69614407D1 DE 69614407 D1 DE69614407 D1 DE 69614407D1 DE 69614407 T DE69614407 T DE 69614407T DE 69614407 T DE69614407 T DE 69614407T DE 69614407 D1 DE69614407 D1 DE 69614407D1
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69614407T
Other languages
English (en)
Other versions
DE69614407T2 (de
Inventor
Jeremy Sargent
John Heal
Fernandez Maria Isab Fernandez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Publication of DE69614407D1 publication Critical patent/DE69614407D1/de
Application granted granted Critical
Publication of DE69614407T2 publication Critical patent/DE69614407T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
DE69614407T 1995-03-29 1996-03-26 Pharmazeutische zusammensetzungen Expired - Fee Related DE69614407T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9506382.2A GB9506382D0 (en) 1995-03-29 1995-03-29 Pharmaceutical compositions
PCT/EP1996/001318 WO1996030364A1 (en) 1995-03-29 1996-03-26 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DE69614407D1 true DE69614407D1 (de) 2001-09-13
DE69614407T2 DE69614407T2 (de) 2002-05-29

Family

ID=10772065

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69614407T Expired - Fee Related DE69614407T2 (de) 1995-03-29 1996-03-26 Pharmazeutische zusammensetzungen

Country Status (7)

Country Link
US (1) US5877175A (de)
EP (1) EP0869956B1 (de)
JP (1) JPH11502825A (de)
AU (1) AU5274096A (de)
DE (1) DE69614407T2 (de)
GB (1) GB9506382D0 (de)
WO (1) WO1996030364A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69934435T2 (de) * 1998-10-20 2007-09-27 University Of North Carolina At Chapel Hill Methoden zum befeuchten der nasenschleimhaut
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US20050025825A1 (en) * 2003-07-31 2005-02-03 Xanodyne Pharmacal, Inc. Tranexamic acid formulations with reduced adverse effects
US7947739B2 (en) 2004-03-04 2011-05-24 Ferring B.V. Tranexamic acid formulations
US20050244495A1 (en) 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20090215898A1 (en) * 2004-03-04 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20060088588A1 (en) * 2004-10-21 2006-04-27 Lourdes Pila-Collazo Medication administering device and system
JO3114B1 (ar) * 2009-02-05 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون
US20100280117A1 (en) * 2009-04-30 2010-11-04 Xanodyne Pharmaceuticals, Inc. Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders
EP2593107A1 (de) * 2010-07-12 2013-05-22 Merck Sharp & Dohme Corp. Tyrosinkinase-hemmer
CN103889974B (zh) 2011-08-22 2017-10-03 武田药品工业株式会社 放射性标记的化合物和它们在哺乳动物中作为磷酸二酯酶(pde10a)的定量成像的放射示踪剂的用途
US11090394B1 (en) 2012-03-27 2021-08-17 Florida A&M University Modified nanodelivery system and method for enhanced in vivo medical and preclinical imaging
MA38427A1 (fr) * 2013-02-21 2018-08-31 Takeda Pharmaceuticals Co Procédé de production d'un composé de pyridazinone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69317436T2 (de) * 1992-11-09 1998-07-02 Knoll Ag 1,4-benzothiazepine verwendbar als neurologische mittel
GB9321162D0 (en) * 1993-10-13 1993-12-01 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
WO1996030364A1 (en) 1996-10-03
GB9506382D0 (en) 1995-05-17
JPH11502825A (ja) 1999-03-09
AU5274096A (en) 1996-10-16
EP0869956A1 (de) 1998-10-14
DE69614407T2 (de) 2002-05-29
US5877175A (en) 1999-03-02
EP0869956B1 (de) 2001-08-08

Similar Documents

Publication Publication Date Title
IS4706A (is) Lyfjasamsetningar
NO20021172L (no) Farmasöytisk sammensetning
BR9610153A (pt) Formulações farmacêuticas
DE69525148T2 (de) Pharmazeutische formulierung
DE69618587D1 (de) Chinazoline und pharmazeutische zusammensetzungen
BR9611367A (pt) Formulação farmacêutic liofilizada estável
DE69621885T2 (de) Neue galenische orale pharmazeutische formulierung
DK0747050T3 (da) Farmaceutiske sammensætninger indeholdende irbesartan
BR9610396A (pt) Formulação farmacêutica
BR9610214A (pt) Compostos farmacéuticos
DE69614407T2 (de) Pharmazeutische zusammensetzungen
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
DE4294862T1 (de) Pharmazeutische Komposition
LV11727A (lv) Farmaceitiska kompozicija
ATE295150T1 (de) Pharmazeutische zusammensetzungen
FI973229A0 (fi) Uusi farmaseuttinen koostumus
ITMI941169A0 (it) Formulazioni farmaceutiche
FI973280A (fi) Farmaseuttinen koostumus
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI973230A (fi) Uusi farmaseuttinen formulaatio
DE69530605D1 (de) Lycopen enthaltende pharmazeutische zusammensetzungen
ATE269695T1 (de) Pharmazeutische pellets
NO965448D0 (no) Farmasöytiske forbindelser
DE19681529D2 (de) Pharmazeutische Darreichungsform
BR9605777A (pt) Composição farmacêutica

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: KNOLL GMBH, 67061 LUDWIGSHAFEN, DE

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee